JBM (Healthcare) Ltd. (HK:2161) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
JBM (Healthcare) Ltd. reported a strong financial performance for the six months ending September 2024, with revenue climbing 22.1% to HK$399 million and profit from operations surging 41.7% to HK$121.6 million compared to the previous year. The company’s profit attributable to equity shareholders rose by 53.4%, amounting to HK$95.9 million. Additionally, JBM declared an interim dividend increase of 59.4%, highlighting its robust growth and commitment to shareholders.
For further insights into HK:2161 stock, check out TipRanks’ Stock Analysis page.